Intranasal oxytocin blunts amygdala response to negative affective stimuli in males and females with alcohol use disorder: a randomized controlled cross-over trial

Negative affect plays a prominent role in the maintenance of alcohol use disorder (AUD) and has been identified as a risk factor for relapse to alcohol. To date, however, treatment options that target negative affective states and consecutive relapse risk in AUD are insufficient. Oxytocin (OXY) migh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Vetter, Sina (VerfasserIn) , Schnabel, Sophia (VerfasserIn) , Reichl, Matthias (VerfasserIn) , Sirignano, Lea (VerfasserIn) , Grinevich, Valéry (VerfasserIn) , Koopmann, Anne (VerfasserIn) , Spanagel, Rainer (VerfasserIn) , Kiefer, Falk (VerfasserIn) , Sommer, Wolfgang H. (VerfasserIn) , Bach, Patrick (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 31 March 2025
In: Psychopharmacology
Year: 2025, Jahrgang: 242, Pages: 1995-2007
ISSN:1432-2072
DOI:10.1007/s00213-025-06779-x
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00213-025-06779-x
Volltext
Verfasserangaben:Sina Vetter, Sophia Schnabel, Matthias Reichl, Lea Sirignano, Valery Grinevich, Anne Koopmann, Rainer Spanagel, Falk Kiefer, Wolfgang Sommer, Patrick Bach
Beschreibung
Zusammenfassung:Negative affect plays a prominent role in the maintenance of alcohol use disorder (AUD) and has been identified as a risk factor for relapse to alcohol. To date, however, treatment options that target negative affective states and consecutive relapse risk in AUD are insufficient. Oxytocin (OXY) might be a promising approach for addressing negative affective states and resulting motivation to use alcohol.
Beschreibung:Gesehen am 17.06.2025
Beschreibung:Online Resource
ISSN:1432-2072
DOI:10.1007/s00213-025-06779-x